Patents
Patents for C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
01/2008
01/23/2008CN100363351C Production of hexyl lactam
01/17/2008US20080015187 Hiv Integrase Inhibitors
01/17/2008US20080015183 Substituted quinazolin-4-ylamine analogues
01/17/2008US20080015180 Methods and compositions for treating amyloid-related diseases
01/17/2008US20080015172 Caspase inhibitors and uses thereof
01/17/2008US20080014269 Oxacarbazepine film-coated tablets
01/16/2008EP1755593B1 Naphthalene derivatives useful as histamine-3-receptor ligands
01/16/2008EP1713778B1 Benzazepine derivatives as histamine h3 antagonists
01/16/2008EP0620003B1 Vasopressin antagonist and oxytocin antagonist
01/16/2008CN101107216A Process for the preparation of fenoldopam mesylate
01/10/2008WO2007050425A3 Lxr modulators
01/10/2008US20080009479 Tetrahydrobenzazepines as Histamine H3 Receptor Ligands
01/10/2008US20080009478 Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2c Receptor Associated Diseases
01/09/2008EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives
01/09/2008EP1282604B1 Substituted caprolactam carbonates and ethers and their use as anti-tumor agents
01/08/2008CA2334298C Neuropeptide y5 receptor antagonists
01/03/2008WO2008000131A1 α-AMINO-N-SUBSTITUTED AMIDE COMPOUNDS, COMPOSITIONS AND USES THEREOF
01/03/2008US20080004256 Amidinophenylalanine Derivatives as Thrombin Inhibitors
01/02/2008EP1873146A2 Bengamide derivatives, method for their manufacture and their application
01/02/2008EP1871761A2 Spirocyclic heterocyclic derivatives and methods of their use
01/02/2008EP1335915B1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents)
01/02/2008CN100358869C Carbamate caspase inhibitors and uses thereof
12/2007
12/27/2007WO2007120589A3 Process for the preparation of caprolactam cgrp antagonist intermediate
12/27/2007US20070299056 Benzazepine derivatives for the treatment of neurological disorders
12/27/2007US20070299053 N-(2-hydroxy-3-methyl-butyryl)-1-(L-alaninyl)-1-amino-3-methyl-4,5,6,7-tetrahydro-2H-3-benzazepin-2-one; inhibiting beta amyloid peptide release and/or synthesis
12/27/2007US20070299052 Inhibitors of IAP
12/27/2007US20070299033 stavudine:melamine co-crystal or stavudine:2-aminopyridine co-crystal; therapeutics; shelf-life, bioavailability
12/26/2007EP1870403A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing -amino acid and derivative thereof with the same
12/26/2007EP1868605A2 Phenyl and pyridyl lta4h modulators
12/26/2007CN101092384A A category of compound of alpha ¿C amido - N ¿C substituent amide, its composition, and application
12/21/2007WO2007026224A3 5-ht1b antagonist composition for depression, anxiety and cognition
12/21/2007CA2654927A1 Substituted phenyl acetic acids as dp-2 antagonists
12/21/2007CA2652669A1 Benzazepinones as sodium channel blockers
12/20/2007US20070293470 Carboxamide Spirolactam Cgrp Receptor Antagonists
12/19/2007EP1347967B1 Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists
12/19/2007EP1032556B1 Pharmaceutically active compounds and methods of use
12/19/2007CN100355729C Pleuromutilin
12/18/2007CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof
12/13/2007WO2007141798A1 Process for producing oxcarbazepine via an 11-alkoxy-10-halo-dihydroiminostilbene intermediate
12/13/2007US20070287698 Tetrahydrobenzo(D)Azepin-2-One Derivatives and the Use Thereof for Treating Cardiovascular Diseases
12/13/2007US20070287697 Cgrp Receptor Antagonists
12/12/2007CN101087773A Inhibitors of c-fms kinase
12/12/2007CN101087761A Tetracyclic indole derivatives as antiviral agents
12/12/2007CN100354266C Prep. of epsilon-hexanolactam
12/12/2007CN100354255C Process for the carbonylation of pentenenitrile
12/11/2007US7307162 Resolution of a narwedine amide derivative
12/11/2007US7307074 Diazepan derivatives or salts thereof
12/11/2007CA2304661C Parenteral formulations comprising carbamazepine or its derivatives
12/06/2007WO2007139215A1 Production method of heterocyclic mercapto compound
12/06/2007WO2007139002A1 Method for producing nitrogen-containing fused ring compound
12/06/2007WO2007138998A1 Pharmaceutical composition comprising nitrogenated fused cyclic compound
12/05/2007EP1362844B1 Benzylamine analogue
12/05/2007CN101084193A Crystalline forms of (r)-8-chloro-1-methyl- 2,3,4,5-tetrahydro-1h-3-benzazepine hydrochloride
12/04/2007US7304088 Peptide like compounds for treating coronavirus or hepatitis C virus; severe acute respiratory distress syndrome
12/04/2007US7304081 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: 1'-{[1-(4-Chlorophenyl)cyclo-pentyl]carbonyl}-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-one; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; antidiabetic agents
12/04/2007US7304056 N-(3-tetrahydrobenzodiazepinonyl)succamides: 2R,3S)N1-[1,3,4,5-tetrahydro-1-(3-phenoxybenzyl)-2-oxo-5-(phenyl)-2H-1,5-benzodiazepin-3-yl]-2-(2-methylpropyl)-3-(propyl)-butanediamide; inhibit production of A beta -peptide, preventing neurological amyloid deposits; Alzheimer's disease
12/04/2007US7304055 Succinoylamino lactams as inhibitors of Aβ protein production
12/04/2007US7304050 Antibacterial agents
12/04/2007US7304049 Succinamides N-monosubstituted with with a dibenzo[b,e]azepinone group that inhibit the production of A beta-peptide, acting to prevent the formation of neurological deposits of amyloid protein; treating Alzheimer's Disease
12/04/2007US7304048 For use as anti-inflammatory agents
11/2007
11/29/2007WO2007135293A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007109615A3 β -LACTAMYL VASOPRESSIN V2 ANTAGONISTS
11/29/2007US20070275949 Benzazepine Derivatives and Methods of Prophylaxis or Treatment of 5Ht2C Receptor Associated Diseases
11/29/2007US20070275948 7-[4-(4-Chlorobenzyloxy)Benzenesulfonyl]-8-Methoxy-3-Methyl-2,3,4,5-Tetrahydro-1h-3-Benzazepinium Maleate Or Tosylate As antipyschotics
11/29/2007CA2649336A1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
11/28/2007EP1860118A2 Immunoadhesin comprising a glycoprotein VI domain
11/28/2007EP1858843A1 Process for making caprolactam
11/28/2007EP1858842A1 Improved method for making caprolactam from impure 6-aminocapronitrile
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/27/2007CA2409344C Method for separating ammonia from solutions containing caprolactam and ammonia
11/22/2007WO2007132841A1 Fused heterocyclic compound and use thereof
11/22/2007US20070270404 Tuberculosis treatment using pleuromutilin derivatives
11/21/2007EP1455777B1 Glyt1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
11/21/2007CN100350036C Apparatus and method for controlling biofilms
11/15/2007US20070265254 Naphthaline derivatives as H3 inverse agonists
11/14/2007EP1854796A1 Optically active ammonium salt compound, production intermediate thereof and method for producing same
11/14/2007CN100348585C Novel method of synthesising 1,3,4,5-tetrahydro-2H-3-benzazepin-2-one derivatives and use thereof in the synthesis of ivabradine and the salts thereof for addition to a pharmaceutically acceptable aci
11/13/2007US7294622 Lactams and uses thereof
11/13/2007CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007WO2007126020A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same
11/08/2007WO2005122671A3 An improved process for the preparation of oxcarbazepine and related intermediates
11/08/2007US20070259854 Triazole Derivative or Salt Thereof
11/08/2007US20070259853 Tetrahydro-1h-1,2,6-triaza-azulene cannabinoid modulators
11/07/2007EP1851196A1 Lactam production method
11/07/2007CN100347157C Method for carrying out high efficiency premixing reaction
11/06/2007CA2228511C New process for preparing norbenzomorphan, an intermediate in the preparation of pharmaceutically useful benzomorphan derivatives, particularly (-)-(1r,5s,2"r)-3'-hydroxy-2-(2-methoxypropyl)-5,9,9-trimethyl-6,7-benzomorphan
11/06/2007CA2223112C 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/01/2007WO2007123516A1 C-fms kinase inhibitors
11/01/2007WO2007121523A1 Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns
11/01/2007US20070255056 Method for manufacture of compounds related to the class of substituted sulfonyl urea anti-diabetics
11/01/2007US20070254869 modulators of Cholesterol ester transfer protein activity, such as 5-[Acetyl-(3,5-bis-trifluoromethyl-benzyl)-amino]-7-trifluoromethyl-2,3,4,5-tetrahydro-benzo[b]azepine-1-carboxylic acid isopropyl ester, for treating or preventing cardiovascular disorders
11/01/2007US20070254868 such as 3-(1-(2,3-difluorophenyl)-1H-tetrazol-5-yl)-5-(4-(4-methylpiperazin-1-yl) phenyl)pyridin-2-amine, used as anticarcinogenic agents or for the treatment of atherosclerosis and lung fibrosis
11/01/2007US20070254341 by organism cell biosynthesis from 6-aminohex-2-enoic acid or transform 6-amino-2-hydroxy-hexanoic acid to 6-aminohex-2-enoic acid, in presence of an enzyme having alpha, beta -enoate reductase; chemical intermediates for nylon-6 production
11/01/2007CA2649512A1 C-fms kinase inhibitors
10/2007
10/31/2007EP1534678B1 Pleuromutilin derivatives as antimicrobbials
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007CN101065362A 2-alcoxy-3,4,5-trihydroxy-alkylamides, preparation thereof, compositions containing them and use thereof
10/31/2007CN101065361A Bengamides with a substituted caprolactame cycle, method forthe preparation thereof, compositions containing them and use thereof
10/31/2007CN101062932A Enantioselective process for the preparation of both enantiomers of 10,11-dihydro-10-hydroxy-5h-dibenz [b,f]azepine-5-carboxamide and new crystal forms thereof
10/30/2007US7288571 Thyroid receptor ligands and method II
1 ... 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 ... 88